Core Viewpoint - *ST SAILONG (002898) has shown a significant increase in stock price, closing at 15.59 yuan, up 4.98% as of August 19, 2025, indicating positive market sentiment despite declining financial performance [1] Financial Performance - The latest quarterly report for *ST SAILONG shows total revenue of 54.09 million yuan, a year-on-year decrease of 22.16% [1] - The net profit attributable to shareholders is 1.04 million yuan, down 163.94% year-on-year [1] - The non-recurring net profit is 1.11 million yuan, reflecting a substantial decrease of 228.58% year-on-year [1] - Key financial ratios include a current ratio of 0.975, a quick ratio of 0.629, and a debt-to-asset ratio of 38.15% [1] Market Activity - The stock experienced a trading volume of 33,600 lots and a transaction amount of 51.56 million yuan [1] - The net inflow of main funds was 11.53 million yuan, accounting for 22.36% of the transaction amount [1] - Large orders saw a net inflow of 13.74 million yuan, representing 26.64% of the transaction amount, while small orders had a net outflow of 6.19 million yuan, making up 12.01% [1] Company Overview - SAILONG Pharmaceutical Group Co., Ltd. was established in 2002 and is located in Zhuhai City, primarily engaged in the pharmaceutical manufacturing industry [2] - The company has a registered capital of 176 million yuan and has made investments in 12 enterprises [2] - SAILONG has participated in 6 bidding projects and holds 32 trademark registrations and 38 patents, along with 39 administrative licenses [2]

Core Viewpoint - *ST Sailong (002898.SZ) has stated on the interactive platform that the company currently has no products related to fentanyl [1] Company Summary - The company has clarified its position regarding fentanyl products, indicating that it does not engage in this segment [1]

WINGONCO(00289.HK)10月24日耗资29.54万港元回购2.3万股 WINGONCO(00289.HK)4月26日耗资3.48 万港元回购2000股 相关事件 格隆汇8月12日丨WING ON CO(00289.HK)公告，公司将于2025年8月26日(星期二)举行董事会会议，以 讨论事项，其中包括批准发布公司及其附属公司截至2025年6月30日止6个月中期业绩及考虑派发中期股 息。 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 的 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全 部 或任何部 分 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 的 任 何 損 失 承 擔 任 何 責 任 。 永安國際有限公司 （「本 公 司 」）董事會 （「董事會 」）謹 此 宣 布 ，本公司將於 2025 年 8 月 26 日（星期 二）舉行 董 事 會會 議，以 討 論事 項，其 中包 括 批准 發布 本 公司 及 其附 屬公 司 截至 2025 年 6 月 30 日止 六 個月 之中 期 業績 及 考慮 派發 中 期股 息 。 WING ON COMPANY INTERNATIONAL LIMITED 永安國際有限公司 (百慕達註冊成立 有限公司 ) (股份代號 ︰289) 董事會 會 議 召開 日期 於本 公 告日 期，本 公司 之 執行 董 事為 郭志 樑 先生（ 主 席）、郭志 桁 先生（ 副 主席 及 行政 總 裁） ...

Core Viewpoint - *ST Sailong, a pharmaceutical company engaged in the full industry chain of drug intermediates, raw materials, formulations, and technical services, faces delisting risk due to negative financial performance in 2024, with a revenue of 264 million yuan and a net profit of -33.14 million yuan [2] Group 1: Financial Performance - In 2024, *ST Sailong achieved an operating income of 264 million yuan and a net profit attributable to shareholders of -33.14 million yuan [2] - The company reported negative values for total profit, net profit, and net profit after deducting non-recurring gains and losses, with operating income below 300 million yuan [2] Group 2: Share Transfer Agreement - On May 18, 2025, the controlling shareholders Cai Nanguai and Tang Lin signed a share transfer agreement with Hainan Yayi, transferring 14.16% of the company's shares, totaling 24.9122 million shares at a price of 8 yuan per share, amounting to 199 million yuan [2] - Following the completion of the share transfer, the controlling shareholder will change from Cai Nanguai and Tang Lin to Hainan Yayi, which currently has no actual controller, resulting in *ST Sailong having no actual controller [2] Group 3: Board Changes - On August 10, 2025, *ST Sailong announced the resignation of several board members, including the chairman and president Cai Nanguai, and the appointment of new non-independent board member candidates [3] - The board approved the appointment of Chen Ke as the new president, who has a background in accounting and investment [4]

Core Viewpoint - *ST Sailong has undergone a change in control, leading to the resignation of all members of its fourth board of directors, including key executives and board members [1][3][4]. Group 1: Board Resignations - The entire fourth board of directors, consisting of 9 members, has submitted resignation reports, including Chairman Cai Nanguai and other key executives [3][4]. - Cai Nanguai will continue to hold other positions within the company after resigning as Chairman, President, and head of the Strategic Decision-Making Committee [3]. - Director Tang Lin has also resigned from all positions within the company, holding 722.39 million shares at the time of resignation [3][4]. Group 2: New Board Candidates - The company has proposed new candidates for the fourth board of directors, including 贾晋斌, 陈科, 陈顿斐, 张光扬, 陈榕辉, and 李童瑶 as non-independent directors, and 王淑芳, 张建民, and 张凯 as independent directors [4]. - The term for the newly nominated directors will last until the end of the current board's term [4]. Group 3: Financial Performance - *ST Sailong has projected a net loss of between 13 million and 18 million yuan for the first half of the year, compared to a profit of 176.47 thousand yuan in the same period last year [7]. - The company reported a basic loss per share of between 0.0739 yuan and 0.1023 yuan, contrasting with a profit of 0.0100 yuan per share in the previous year [7]. - As of August 8, the company's stock price closed at 16.81 yuan per share, with a total market capitalization of 2.959 billion yuan [8].

Core Viewpoint - *ST Sailong has experienced a complete resignation of its board members, indicating a significant change in corporate governance and potential implications for the company's future direction [1][3][4]. Board Resignation - All nine members of the fourth board of directors of *ST Sailong have submitted their resignation reports, including key figures such as Chairman Cai Nanguai and other executives [3][4]. - Cai Nanguai will continue to hold other positions within the company despite resigning as Chairman and CEO, and he holds 67.51 million shares, representing 47.23% of the company’s controlling shareholder [3][4]. - The resignations will lead to a board composition below the minimum required by the company's articles of association, necessitating the continuation of their roles until new directors are elected [4]. New Board Candidates - The board has proposed new candidates for the fourth board of directors, including non-independent and independent directors, to be elected at the upcoming shareholders' meeting [4][5]. Management Changes - The board has approved the appointment of Chen Ke as the new CEO, effective immediately following the board meeting [5]. - Chen Ke has a background in accounting and has held various positions in investment and asset management [6]. Financial Performance - *ST Sailong has projected a net loss of between 13 million and 18 million yuan for the first half of the year, a significant decline from a profit of 1.76 million yuan in the same period last year [7]. - The expected loss translates to a basic earnings per share loss of between 0.0739 yuan and 0.1023 yuan, compared to a profit of 0.0100 yuan per share in the previous year [7]. Stock Market Activity - On August 8, *ST Sailong's stock price reached a limit-up, closing at 16.81 yuan per share, with a total market capitalization of 2.959 billion yuan [7][8].

8月10日晚间，*ST赛隆公告称，因公司控制权已发生变更，公司第四届董事会所有成员和部分高管均递交了辞职报告。 同时，海南雅亿共赢科技合伙企业（有限合伙）（以下简称海南雅亿）作为*ST赛隆的新任控股股东，提名贾晋斌等9人为*ST赛隆第四届董事会的董事候 选人。 8月8日尾盘，*ST赛隆突然涨停。截至当日收盘，*ST赛隆股价报16.81元/股，涨幅达5%，总市值为29.59亿元。 董事会所有成员辞职 *ST赛隆公告称，近日，公司收到董事长兼总裁蔡南桂、董事唐霖、董事兼常务副总裁刘达文、董事兼副总裁李剑峰、董事邓拥军、独立董事潘传云、独 立董事陈小辛、独立董事李公奋，以及董事、副总裁、董事会秘书张旭等9人递交的辞职报告。 *ST赛隆将迎新一任管理层 *ST赛隆公告称，蔡南桂等人申请辞去公司董事等职务，主要是公司控制权已经发生变更。 7月9日，*ST赛隆收到蔡南桂、唐霖与海南雅亿的通知，获悉蔡南桂、唐霖向海南雅亿协议转让所持*ST赛隆14.16%股份的过户登记手续已经办理完成， 并且取得中国证券登记结算有限责任公司出具的《证券过户登记确认书》。 目前，*ST赛隆第四届董事会共有9名董事。这意味着，*ST赛隆第四届董 ...

Group 1 - The company *ST Sailong (002898.SZ) announced a change in control, leading to the resignation of several key executives including the chairman and president Cai Nanguai, and other board members [1] - The resigning board members will continue to fulfill their duties until new directors are elected at the shareholders' meeting [1] - The company will expedite the process of board member replacement in accordance with relevant regulations [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 永安國際有限公司 (百慕達註冊成立有限公司) 呈交日期: 2025年8月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00289 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 400,000,000 | HKD | | 0.1 | HKD | | 40,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 400,000,000 | HKD | | 0.1 | HKD | | 40,000,000 | 第 2 ...